Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Willmann

Showing results (11-20 of 80) with videos related to

Pageof 8
Sort By:
Pharmaceutical Research|December 10, 2003
A physiologic model for simulating gastrointestinal flow and drug absorption in ratsStefan Willmann, Walter Schmitt, Jörg Keldenich, et al.
Clinical Pharmacokinetics|June 29, 2006
A mechanistic approach for the scaling of clearance in childrenAndrea N Edginton, Walter Schmitt, Barbara Voith, et al.
Clinical Pharmacokinetics|April 24, 2009
Defining the role of macrophages in local moxifloxacin tissue concentrations using biopsy data and whole-body physiologically based pharmacokinetic modellingAndrea N Edginton, Gertrud Ahr, Stefan Willmann, et al.
Frontiers in Physiology|February 14, 2013
A detailed physiologically based model to simulate the pharmacokinetics and hormonal pharmacodynamics of enalapril on the circulating endocrine Renin-Angiotensin-aldosterone systemKarina Claassen, Stefan Willmann, Thomas Eissing, et al.
The AAPS Journal|August 24, 2022
Nifurtimox for Treatment of Chagas Disease in Pediatric Patients: the Challenges of Applying Pharmacokinetic-Pharmacodynamic Principles to Dose FindingHeino Stass, Ibrahim Ince, Ulrike Grossmann, et al.
Expert Opinion on Drug Metabolism & Toxicology|August 30, 2008
Whole body physiologically-based pharmacokinetic models: their use in clinical drug developmentAndrea N Edginton, Frank-Peter Theil, Walter Schmitt, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 19, 2023
Longitudinal observations of TFPI levels in paediatric Haemophilia A patientsStephan Schwers, Anita Shah, Camila Linardi, et al.
Frontiers in Pharmacology|April 7, 2017
Addressing Adherence Using Genotype-Specific PBPK Modeling-Impact of Drug Holidays on Tamoxifen and Endoxifen Plasma LevelsKristin J R Dickschen, Stefan Willmann, Georg Hempel, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|June 18, 2010
Mechanism-based prediction of particle size-dependent dissolution and absorption: cilostazol pharmacokinetics in dogsStefan Willmann, Kirstin Thelen, Corina Becker, et al.
Journal of Pharmaceutical Sciences|November 30, 2011
Evolution of a detailed physiological model to simulate the gastrointestinal transit and absorption process in humans, part II: extension to describe performance of solid dosage formsKirstin Thelen, Katrin Coboeken, Stefan Willmann, et al.
Pageof 8

Showing results (11-20 of 80) with videos related to

Sort By:
Pageof 8
Pharmaceutical Research|December 10, 2003
A physiologic model for simulating gastrointestinal flow and drug absorption in ratsStefan Willmann, Walter Schmitt, Jörg Keldenich, et al.
Clinical Pharmacokinetics|June 29, 2006
A mechanistic approach for the scaling of clearance in childrenAndrea N Edginton, Walter Schmitt, Barbara Voith, et al.
Clinical Pharmacokinetics|April 24, 2009
Defining the role of macrophages in local moxifloxacin tissue concentrations using biopsy data and whole-body physiologically based pharmacokinetic modellingAndrea N Edginton, Gertrud Ahr, Stefan Willmann, et al.
Frontiers in Physiology|February 14, 2013
A detailed physiologically based model to simulate the pharmacokinetics and hormonal pharmacodynamics of enalapril on the circulating endocrine Renin-Angiotensin-aldosterone systemKarina Claassen, Stefan Willmann, Thomas Eissing, et al.
The AAPS Journal|August 24, 2022
Nifurtimox for Treatment of Chagas Disease in Pediatric Patients: the Challenges of Applying Pharmacokinetic-Pharmacodynamic Principles to Dose FindingHeino Stass, Ibrahim Ince, Ulrike Grossmann, et al.
Expert Opinion on Drug Metabolism & Toxicology|August 30, 2008
Whole body physiologically-based pharmacokinetic models: their use in clinical drug developmentAndrea N Edginton, Frank-Peter Theil, Walter Schmitt, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 19, 2023
Longitudinal observations of TFPI levels in paediatric Haemophilia A patientsStephan Schwers, Anita Shah, Camila Linardi, et al.
Frontiers in Pharmacology|April 7, 2017
Addressing Adherence Using Genotype-Specific PBPK Modeling-Impact of Drug Holidays on Tamoxifen and Endoxifen Plasma LevelsKristin J R Dickschen, Stefan Willmann, Georg Hempel, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|June 18, 2010
Mechanism-based prediction of particle size-dependent dissolution and absorption: cilostazol pharmacokinetics in dogsStefan Willmann, Kirstin Thelen, Corina Becker, et al.
Journal of Pharmaceutical Sciences|November 30, 2011
Evolution of a detailed physiological model to simulate the gastrointestinal transit and absorption process in humans, part II: extension to describe performance of solid dosage formsKirstin Thelen, Katrin Coboeken, Stefan Willmann, et al.
Pageof 8